Podio GAY, Herrero SY, Arias MY, Cabrera HY

Language: Spanish
References: 12
Page:
PDF size: 163.52 Kb.

ABSTRACT

Peripheral facial paralysis is a very frequent neurological affectation and in most cases it is not possible to establish an accurate etiology, calling them idiopathic or Bell's facial paralysis. The study was conducted with the objective of evaluating the effectiveness of combined laser and magneto rehabilitation treatment in patients with peripheral facial paralysis. We performed a quasi-experimental modality before and after without a control group in 37 patients with peripheral facial paralysis who attended the Physiatry Consultation of the "Máximo Gómez Báez" Polyclinic in the municipality of Río Cauto from January 2017 to January 2019 The comorbidity of peripheral facial paralysis with other chronic and infectious diseases was studied, resulting that herpes simplex and otitis were the most significant for 40,54 and 24,32% respectively; there were no complications during the combined therapy in 83,78%; the level of severity was normal (83,78%), mild (13, 51 %) and moderate (2,70%); the treatment was effective in 83,78% of the patients. It is concluded that the combined rehabilitation treatment of laser and magneto in patients with peripheral facial paralysis is effective.

REFERENCES

1. Ramos García IY, Noa Muguercia H. Acupuntura y masaje tuina en el tratamiento de la parálisis de Bell. Rev Ciencias Médicas 2019; 23(4): 533-541.

2. Terán Loredo J, Rayas Lundes J, Torres Vega O, Millán Games Y, Farrel Gonzáles L. Diagnóstico y tratamiento del adulto con parálisis de Bell en el primer y segundo nivel de Atención: Guía de práctica clínica. Evidencias y Recomendaciones. [Internet]. México, DF: Instituto Mexicano de Seguro Social; 2017. [Citado 27/3/2020]. Disponible en: http://www.imss.gob.mx/sites/all/statics/guiasclinicas/066GER.pdf.

3. González Galeano MCC. Gestante de 37 semanas con parálisis facial periférica. Rev. virtual Soc. Parag. Med. Int. 2018; 5(2): 85-88.

4. Cappeli AJ, Nunes Hélio RC, Gameiro MO, Bazán R, Luvizutto GJ. Main prognostic factors and physical therapy modalities associated with functional recovery in patients with peripheral facial paralysis. Fisioter Pesqui 2020; 27(2):180-187.

5. Lugones Botell M, Bueno Hidalgo M, Jaime Álvarez A. Parálisis facial y preeclampsia. Rev Cubana Obstetr Ginecol 2017; 43(1): 1-13.

6. Herrera Santos MB, Valenzuela Fonseca L, Torres Alvarado M. Aplicación de magnetoterapia y craneopuntura en un paciente con cuadriparesia. MEDISAN 2018; 22(7): 567-577.

7. Rodríguez PD, Costa DR, Prianti BM, Costa DR, Delpasso CA, Arisawa EÂ, et al. Association of facial massage, dry needling, and laser therapy in Temporomandibular Disorder: case report. CoDAS 2018; 30(6): e20170265.

8. Molina Duche G, Ortiz Cajías M. Ejercicios fisioterapéuticos faciales para la recuperación de pacientes en parálisis facial periférica que acuden al área de terapia física del centro de salud tipo c "Espoch-Lizarzaburu" julio-diciembre 2016. [Tesis]. Ecuador: Universidad Nacional de Chimborazo; 2017. [Citado 27/3/2020]. Disponible en: http://dspace.unach.edu.ec/bitstream/51000/3654/1/UNACH-EC-FSC-TER-FIS-2017-0012.pdf.

9. Loeb LM, Amorim RP, Mazzacoratti MGN, Scorza FA, Peres MFP. Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison. Arq Neuro-Psiquiatr 2018; 76(10): 663-667.

10. Martínez Pérez JR, López Ocaña L, Goodridge Altabás N, Rodríguez Ávila Y, Gómez Fernández K. Efectividad de la combinación magnetoterapia laserterapia homeopatía en el tratamiento del mioma uterino. Rev Electrónica Zoilo E. Marinello Vidaurreta [Internet]. 2016 [citado 17/1/2020];41(12). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/990.

11. Cardentey García J, González García X, Porras Mijants O. Efectividad de la magnetoterapia en la terapéutica de las alveolitis. AMC 2016; 20(4): 386-93.

12. Pérez Morales VS, Peñaranda Calzado MA, Torres Nieves JC. Láser de baja potencia en la cicatrización de heridas. Mediciego 2017; 23(4): 49-54.